title: [Debut in diabetic patients with hepatitis C treatment with ledipasvir/ sofosbuvir (Harvoni®)].
authors.affiliation: Servicio de Farmacia, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia.. sergiovicente87@hotmail.com.
authors.forename: Sergio
authors.initials: S
authors.lastname: Vicente-Sánchez
authors.affiliation: Servicio de Farmacia, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia.. sergiovicente87@hotmail.com.
authors.forename: Laura
authors.initials: L
authors.lastname: Menéndez Naranjo
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D048909:Diabetes Complications / Q000188:drug therapy*; D005449:Fluorenes / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000069474:Sofosbuvir / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; C586541:ledipasvir; D000069474:Sofosbuvir